Purinergic Signal
Purinergic Signalling
1573-9538
1573-9546
Springer Netherlands
Dordrecht


2072912
18404448
9060
10.1007/s11302-007-9060-4
Original Paper


3
H]Adenine is a suitable radioligand for the labeling of G protein-coupled adenine receptors but shows high affinity to bacterial contaminations in buffer solutions

Schiedel
Anke C.

1

Meyer
Heiko

1

Alsdorf
Bernt B.A.

1

Gorzalka
Simone

1

Brüssel
Hannelore

2

Müller
Christa E.

+49-228-732301
+40-228-732567
christa.mueller@uni-bonn.de

1
3

1
University of Bonn, Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB), Pharmaceutical Chemistry I, Bonn, Germany 
2
University of Bonn, Institute of Animal Science, Physiology & Hygiene Group, Bonn, Germany 
3
Pharmazeutisches Institut, Pharmazeutische Chemie I, An der Immenburg 4, 53121 Bonn, Germany 

25
7
2007

9
2007

3
4
347
358
3
6
2007

25
6
2007


© Springer Science + Business Media B.V. 2007

3
3
3
3
Achromobacter xylosoxidans
A. denitrificans
Acinetobacter lwoffii
A. xylosoxidans
3
A. xylosoxidans
3
H]adenine is a well-suitable radioligand for adenine receptor binding studies but that bacterial contamination of the employed buffer solutions must be avoided.

Keywords
Achromobacter

Acinetobacter

Adenine receptor
Bacterial buffer contamination
G protein-coupled receptor
Nosocomial infection
Purine transporter
Purinergic receptor
Radioligand binding studies
3
H]adenine

issue-copyright-statement
© Springer Science+Business Media B.V. 2007




Introduction
1
2
4
1
2A
2B
3
2
4
5
5
6
i
5
6
7
8
] based on the structural relationships of the physiological agonists, adenine (P0) representing a partial structure of adenosine (P1) and adenosine again being a partial structure of adenine nucleotides (P2), such as adenosine triphosphate (ATP) or adenosine diphosphate (ADP).
9
3
5
7
10
10
3
7
3
6
].
3
i
11
max
2+
11
3
3
12
50
12
7
5
12
7
12
7
50
12
10
12
7
12
7
10
3
12
].
3
3
3
H]adenine.

Materials and methods
Chemicals
3
H]Adenine (27 Ci/mmol) was obtained from Amersham Biosciences (Munich, Germany). Tris was obtained from Acros Organics (Leverkusen, Germany) and dimethyl sulfoxide (DMSO) was from Fluka (Switzerland). All other chemicals and reagents were obtained from Sigma unless otherwise noted.

Cell culture
2
) in Dulbecco’s modified Eagle medium (DMEM) containing 10% fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2 mM L-glutamine.

Membrane preparations
7
13
14
7
13
15
].

3
H]Adenine binding assays
7
2+
2+
i
3
H]adenine in 50 mM Tris-HCl, pH 7.4 in a total volume of 200 μl. Inhibition curves were determined using six to nine different concentrations of adenine, spanning three orders of magnitude. Three separate experiments were performed, each in triplicate, unless otherwise noted. Nonspecific binding was determined in the presence of 100 μM unlabeled adenine. Incubations were carried out for 1 h at room temperature and terminated by rapid filtration through GF/B glass fiber filters (Whatman, Dassel, Germany). Filters were washed three times, 2 ml each, with freshly prepared ice-cold 50 mM Tris-HCl buffer, pH 7.4 and immediately transferred to mini vials. Scintillation cocktail (Ultima Gold, Canberra Packard, 2.5 ml) was added and after an incubation of 9 h filter-bound radioactivity was measured by liquid scintillation counting at an efficiency of 54%. In some experiments, the addition of mammalian protein was omitted and replaced by 100 μl of different buffer samples. For competition experiments with bacteria, either 100 μl of 1:100 or 1:1000 dilution of an overnight culture of the bacteria in Tris buffer, 50 mM, pH 7.4, or a membrane preparation of bacteria (containing 0.4–10 μg of protein) was used.
4
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{OD}}_{{600}}  = 1\;{\text{equals}}\;3 \times 10^{8} \;{{\text{cells}}} \mathord{\left/  {\vphantom {{{\text{cells}}} {{\text{ml}}}}} \right.  \kern-\nulldelimiterspace} {{\text{ml}}} $$\end{document}

16
].

Data analysis
50
 values were determined by fitting data to sigmoidal concentration-inhibition curves. Results are presented as means ± standard error of the mean (SEM) from the number of observations.

Isolation of microorganisms from contaminated buffer solutions and classification
 Bergey’s Manual of Systematic Bacteriology
17
]. In addition, the following kits and appliances were used: BBL OXI/FERM Tube II (Schwarz Pharma GmbH, Germany), API 20 NE strips and apiweb software (Biomerieux, Nürtingen, Germany), and VITEK 2 fully automated system (Biomerieux, Nürtingen, Germany).


Results
3
H]adenine binding
3
1
3
1
Fig. 1
3
a
b
c
3
n
 = 3). Nonspecific binding was determined in the presence of 100 μM adenine





Microbial contaminations in buffer solutions
3
3
3
3
3
6
3
1
18
3
3
m
2A
19
3
R
H
3
20
12
3
21
] did not show any specific binding to that buffer solution.
2
3
3
3
3
3
3
3
3
Fig. 2
3
3
H]adenine binding. The results shown represent means of three independent experiments ± standard error of the mean





Isolation of microbial buffer contaminants
3
3
Fig. 3
3
a
b
50
a
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{rat}}\,{\text{cortex}} = 57.0 \pm 4.4\;{\text{nM}}{\left( {n = 3} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{contaminant}}\;1 = 4.59 \pm 0.49\;{\text{nM}}{\left( {n = 3} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{contaminant}}\;2 = 1,010 \pm 240\;{\text{nM}}{\left( {n = 2} \right)}$$\end{document}

n
50
b
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Achromobacter\,xylosoxidans = 13.8 \pm 2.7\;{\text{nM}}{\left( {n = 8} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Achromobacter\,denitrificans = 253 \pm 46\;{\text{nM}}{\left( {n = 5} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$Acinetobacter\,lwoffii = 299 \pm 129\;{\text{nM}}{\left( {n = 5} \right)}$$\end{document}






\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 4.59 \pm 0.49\;{\text{nM}}\;{\text{vs}}{\text{.}}\;10\;{\text{nM}}\;{\left[ {^{3} {\text{H}}} \right]}{\text{adenine}} $$\end{document}

 n
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 1008 \pm 240\;{\text{nM}} $$\end{document}

 n
50
 n
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 57.0 \pm 4.4\;{\text{nM}} $$\end{document}

3
a). Using amounts of membrane preparations of contaminant 1 that contained more than 1 μg protein/assay tube led to depletion of the radioligand (more than 50% of the added radioligand was bound to the protein) (data not shown).

Identification of microbial contaminants
1
Pseudomonas 
Achromobacter
Achromobacter 
Acinetobacter 
17
Acinetobacter
A. lwoffii
A. xylosoxidans
A. denitrificans
1
Achromobacter
Achromobacter
1
1
Table 1
Summary of classification test results using standard procedures and kits

Test
Contaminant 1
Contaminant 2
Contaminant 3


Morphology of colonies

  Form
Round
Round
Round

  Diameter
1–2 mm
1 mm
1 mm

  Color
Grey
Beige
White

  Brim
Smooth
Smooth
Smooth

  Surface
Shiny
Shiny
Shiny

  Cross section
Raised
Raised
Raised

  Gram stain
Negative
Negative
Negative

Biochemistry

  Catalase
+
+
+

  Oxidase
+
+
–

  O/F test
–/–
–/–
–/–

  Motility
+
+
–

  Lysine/BBL Ox/Ferm Tube II
–
+
n.d.

  Result
Achromobacter 
Pseudomonas 
spp.
Achromobacter 
spp.
Acinetobacter 
spp.

Api 20 NE

3
, nitrate reduction
+
+
–

  GLU, glucose
+
–
–

  GNT, gluconate
+
+
–

  CAP, caprate
+
–
+

  ADI, adipate
+
+
–

  MLT, maltose
+
+
+

  CIT, citrate
+
+
–

  PAC, phenylacetate
+
+
+

  OX, oxidase
+
+
–

  Result
A. xylosoxidans
 (94.5%)
A. denitrificans
 (82.2%)
A. lwoffii
 (98.1%)

VITEK 2

  N-LGGH, γ-L-glutamyl (nutrient assimilation, NA)
+
+
n.d.

  P-BPHO, bis(p-nitrophenyl)phosphate
+
–
n.d.

  C-CIT, citrate
–
+
n.d.

  C-KGA, α-acetoglutaryc acid
+
+
n.d.

  N-LPROT, L-proline-NA
+
–
n.d.

  Result
Achromobacter 
spp. (90%)
Achromobacter 
spp. (90%)
n.d.



 n.d. 
not determined




3
H]Adenine binding assays with isolated, intact bacteria
3
50
A. xylosoxidans
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 13.8 \pm 2.7\;{\text{nM}} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 4.59 \pm 0.49 $$\end{document}

A. denitrificans
A. lwoffii
50
D
max
A. xylosoxidans
D
max
n
D
max
n
 = 8) was obtained.

Structure–activity relationships
A. xylosoxidans
7
4
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 13.8 \pm 2.7\;{\text{nM}} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 59.1 \pm 19.6\;{\text{nM}} $$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{IC}}_{{50}}  = 32,100 \pm 3000\;{\text{nM}} $$\end{document}

2
A. xylosoxidans
i
3
50
i
7
50
A. xylosoxidans
Fig. 4
3
Achromobacter xylosoxidans
\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{IC}}_{{50}} \,{\text{values}}:\,{\text{adenine}} = 13.8 \pm 2.7\;{\text{nM}}\;{\left( {n = 8} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$${\text{hypoxanthine}} = 59.1 \pm 19.6\;{\text{nM}}\;{\left( {n = 3} \right)}$$\end{document}

\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$2 - {\text{fluoroadenine}} = 32,100 \pm 3000\;{\text{nM}}\;{\left( {n = 3} \right)}$$\end{document}





Table 2
Comparison of affinities of adenine and selected compounds for the rat adenine receptor and bacterial binding sites determined in radioligand binding studies

Compound
Achromobacter xylosoxidans
 (intact bacteria)
Rat brain cortical membranes

50
a
 (% inhibition ± SEM at 10 μM)
i
a
 (% inhibition ± SEM at 100 μM)


Adenine
b

c


2-Fluoroadenine
32.1 ± 3.0
c


2-Hydroxyadenine
d

29.4 ± 6.4

2,6-Diaminopurine
d

4.95 ± 0.75

6
-Ethenoadenine
d

34.4 ± 8.1

Hypoxanthine
0.0591 ± 0.0196
45.0 ± 19.4

Uracil
≫10 (6 ± 1)
≫100 (−6 ± 2)

Xanthine
>10 (17 ± 6)
>100 (23 ± 7)

Uridine
d

≫100 (−9 ± 3)

Adenosine
d

c




a
Results are from three independent experiments performed in triplicate, unless otherwise noted
b
Results are from eight independent experiments performed in triplicate
c
i
7
]
d
Results from two independent experiments performed in triplicate





Discussion
3
6
7
5
10
3
11
12
3
11
12
12
3
3
H]adenine binding results that we had obtained during the past years, trying to find an explanation for the discrepancies.
12
3
1
3
1
3
3
3
3
6
].
3
3
12
3
11
12
].
3
12
3
12
3
3
3
H]adenine binding was abolished, strongly indicating that microbial proteins were responsible for the high affinity binding of adenine. A further indication that a living organism was involved was the fact that adenine binding increased exponentially with time. Interestingly, the microorganisms grew better at 4°C than at room temperature.
Saccharomyces cerevisiae
3
Achromobacter
Acinetobacter
17
A. xylosoxidans
A. lwoffii
22
32
17
24
26
33
36
]. This is consistent with the fact that these bacteria are able to grow in simple Tris-HCl buffer at low temperature.
A. lwoffii
Achromobacter 
50
A. xylosoxidans
A. xylosoxidans
7
5
6
A. lwoffii
A. denitrificans
A. xylosoxidans
3
3
A. xylosoxidans
 appeared to be expressed in extraordinarily high density, as amounts of membrane preparations that contained more than 1 μg of protein/assay tube led to depletion of the radioligand (i.e., more than 50% of the added radioligand was bound to the protein). Rough estimations of receptor densities by homologous competition assays confirmed the high expression levels.
37
Escherichia coli
Bacillus
Aspergillus nidulans
Neurospora crassa
37
39
40
41
E. coli
42
3
A. xylosoxidans
43
44
Trypanosoma brucei brucei
Crithidia luciliae
44
45
].
E. coli
B. subtilis
42
46
47
46
47
3
Achromobacter
Acinetobacter
42
47
].
A. xylosoxidans
Achromobacter
 binding sites.
3
11
12
12
10
12
7
12
3
A. xylosoxidans
 in the same concentration range as adenine itself is another indication that the labeled protein may be a purine transporter.
37
48
37
48
52
46
53
C. luciliae
45
E. coli
53
B. subtilis
46
].
A. baumannii
Pseudomonas 
3
Achromobacter 
spp., a bacterium isolated as a contaminant from Tris-HCl buffer. The high affinity in the low nanomolar range is in fact unusual; therefore, it may be speculated that the labeled protein might belong to a new type of high-affinity bacterial nucleobase transporter.

Conclusions
3
3
A. lwoffii
A. xylosoxidans,
A. denitrificans
3
H]adenine.


Acknowledgements
This work was supported by the Deutsche Forschungsgemeinschaft (GRK 677). Thanks are due to Hannah Ulm, undergraduate student of molecular biomedicine, for performing some of the binding experiments, and Sylvia Hack, from the Hygiene Institute of the University of Bonn, for running identification procedures (Api 20 NE and VITEK systems).

References
1.
Burnstock
G


Physiology and pathophysiology of purinergic neurotransmission
Physiol Rev
2007
87
659
797
10.1152/physrev.00043.2006

17429044


2.
Fredholm
BB

IJzerman
AP

Jacobson
KA

Klotz
KN

Linden
J


International Union of Pharmacology XXV. Nomenclature and classification of adenosine receptors
Pharmacol Rev
2001
53
527
552

11734617


3.
Kügelgen
I

Wetter
A


Molecular pharmacology of P2Y-receptors
Naunyn Schmiedeberg’s Arch Pharmacol
2000
362
310
323
10.1007/s002100000310

von Kügelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedeberg’s Arch Pharmacol 362:310–323 

4.
Khakh
BS

North
RA


P2X receptors as cell-surface ATP sensors in health and disease
Nature
2006
442
527
532
10.1038/nature04886

16885977


5.
Bender
E

Buist
A

Jurzak
M

Langlois
X

Baggerman
G

Verhasselt
P

Ercken
M

Guo
HQ

Wintmolders
C

Wyngaert
I

Oers
I

Schoofs
L

Luyten
W


Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule
Proc Natl Acad Sci USA
2002
99
8573
8578
10.1073/pnas.122016499

12084918


6.
i
 protein-coupled receptor for adenine from mouse brain, submitted

7.
Gorzalka
S

Vittori
S

Volpini
R

Cristalli
G

Kügelgen
I

Müller
CE


Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues
Mol Pharmacol
2005
67
955
964
10.1124/mol.104.006601

15604413


8.
Brunschweiger
A

Müller
CE


P2 receptors activated by uracil nucleotides—an update
Curr Med Chem
2006
13
289
312
10.2174/092986706775476052

16475938


9.
Bylund
DB

Toews
ML


Radioligand binding methods: practical guide and tips
Am J Physiol
1993
265
L421
L429

8238529


10.
Watanabe
S

Ikekita
M

Nakata
H


3
H]adenine-binding sites in rat brain membranes
J Biochem (Tokyo)
2005
137
323
329

15809333


11.
3
http://www.pa2online.org/Vol2Issue4abst120P.html


12.
3
H]Adenine’s high filter binding precludes its use as a radioligand for the adenine receptor. Purinergic Signaling 2:71–72

13.
Griessmeier
KJ

Müller
CE


3
A
 receptors in human astrocytoma 1321N1 cells and screening of potential ligands
Pharmacology
2005
74
51
56
10.1159/000083983

15714006


14.
Klotz
KN

Hessling
J

Hegler
J

Owman
C

Kull
B

Fredholm
BB

Lohse
MJ


Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells
Naunyn Schmiedeberg’s Arch Pharmacol
1998
357
1
9
10.1007/PL00005131

Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg’s Arch Pharmacol 357:1–9 

15.
Lowry
OH

Rosebrough
NJ

Farr
AL

Randall
RJ


Protein measurement with the folin phenol reagent
J Biol Chem
1951
193
265
275

14907713


16.
Bergonzelli
GE

Donnicola
D

Porta
N

Corthesy-Theulaz
IE


Helicobacter
 infection
Antimicrob Agents Chemother
2003
47
3240
3246
10.1128/AAC.47.10.3240-3246.2003

14506036


17.
Garrity
GM


Bergey’s manual of systematic bacteriology
1984
Baltimore
Williams and Wilkins

Garrity GM (1984) Bergey’s manual of systematic bacteriology. Williams and Wilkins, Baltimore 

18.
Klotz
KN

Lohse
MJ

Schwabe
U

Cristalli
G

Vittori
S

Grifantini
M


6
3
3
1
 adenosine receptors
Naunyn Schmiedeberg’s Arch Pharmacol
1989
340
679
683
10.1007/BF00717744

Klotz KN, Lohse MJ, Schwabe U, Cristalli G, Vittori S, Grifantini M (1989) 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA) - a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedeberg’s Arch Pharmacol 340:679–683 

19.
Müller
CE

Maurinsh
J

Sauer
R


3
m
2A
 adenosine receptors
Eur J Pharm Sci
2000
10
259
265
10.1016/S0928-0987(00)00064-6

10838015


20.
Müller
CE

Diekmann
M

Thorand
M

Ozola
V


3
R
H
i
3
3
 adenosine receptors
Bioorg Med Chem Lett
2002
12
501
503
10.1016/S0960-894X(01)00785-5

11814828


21.
El-Tayeb
A

Griessmeier
KJ

Müller
CE


3
12
 receptors
Bioorg Med Chem Lett
2005
15
5450
5452
10.1016/j.bmcl.2005.08.104

16213725


22.
Spear
JB

Fuhrer
J

Kirby
BD


Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans)
 bacteremia associated with a well-water source: case report and review of the literature
J Clin Microbiol
1988
26
598
599

3281982


23.
Weitkamp
JH

Tang
YW

Haas
DW

Midha
NK

Crowe
JE


Achromobacter xylosoxidans
 bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome
Clin Infect Dis
2000
31
1183
1187
10.1086/317461

11073750


24.
Granowitz
EV

Keenholtz
SL


Alcaligenes xylosoxidans
 attributable to contaminated saline
Am J Infect Control
1998
26
146
148
10.1016/S0196-6553(98)80035-7

9584810


25.
Reverdy
ME

Freney
J

Fleurette
J

Coulet
M

Surgot
M

Marmet
D

Ploton
C


Achromobacter xylosoxidans

J Clin Microbiol
1984
19
140
143

6699141


26.
Shigeta
S

Yasunaga
Y

Honzumi
K

Okamura
H

Kumata
R

Endo
S


Achromobacter xylosoxidans

J Clin Pathol
1978
31
156
161
10.1136/jcp.31.2.156

632360


27.
Powell
S

Perry
J

Meikle
D


Microbial contamination of non-disposable instruments in otolaryngology out-patients
J Laryngol Otol
2003
117
122
125
10.1258/002221503762624567

12625885


28.
Patil
JR

Chopade
BA


in vitro
Acinetobacter
 species on the skin of healthy humans
Natl Med J India
2001
14
204
208

11547525


29.
Gennari
M

Lombardi
P


Acinetobacter
 strains isolated from different foods and clinical sources
Zentralbl Bakteriol
1993
279
553
564

8305813


30.
Seifert
H

Baginski
R

Schulze
A

Pulverer
G


Acinetobacter
 species in clinical culture materials
Zentralbl Bakteriol
1993
279
544
552

8305812


31.
Musa
EK

Desai
N

Casewell
MW


Acinetobacter calcoaceticus
 inoculated on fingertips and on formica
J Hosp Infect
1990
15
219
227
10.1016/0195-6701(90)90029-N

1971628


32.
Bouvet
PJ

Grimont
PA


Acinetobacter

Ann Inst Pasteur Microbiol
1987
138
569
578
10.1016/0769-2609(87)90042-1

3440090


33.
Abd-El-Haleem
D

Zaki
S

Abulhamd
A

Elbery
H

Abu-Elreesh
G


Acinetobacter
 bioreporter assessing heavy metals toxicity
J Basic Microbiol
2006
46
339
347
10.1002/jobm.200510122

17009289


34.
Krauter
P

Daily
B

Dibley
V

Pinkart
H

Legler
T


Perchlorate and nitrate remediation efficiency and microbial diversity in a containerized wetland bioreactor
Int J Phytoremediat
2005
7
113
128
10.1080/16226510590950414

Krauter P, Daily B Jr, Dibley V, Pinkart H, Legler T (2005) Perchlorate and nitrate remediation efficiency and microbial diversity in a containerized wetland bioreactor. Int J Phytoremediat 7:113–128 

35.
Andreoni
V

Cavalca
L

Rao
MA

Nocerino
G

Bernasconi
S

Dell’Amico
E

Colombo
M

Gianfreda
L


Bacterial communities and enzyme activities of PAHs polluted soils
Chemosphere
2004
57
401
412
10.1016/j.chemosphere.2004.06.013

15331267


36.
Vinas
M

Sabate
J

Espuny
MJ

Solanas
AM


Bacterial community dynamics and polycyclic aromatic hydrocarbon degradation during bioremediation of heavily creosote-contaminated soil
Appl Environ Microbiol
2005
71
7008
7018
10.1128/AEM.71.11.7008-7018.2005

16269736


37.
Koning
H

Diallinas
G


Nucleobase transporters (review)
Mol Membr Biol
2000
17
75
94
10.1080/09687680050117101

10989458


38.
Amillis
S

Cecchetto
G

Sophianopoulou
V

Koukaki
M

Scazzocchio
C

Diallinas
G


Aspergillus nidulans
 conidia
Mol Microbiol
2004
52
205
216
10.1046/j.1365-2958.2003.03956.x

15049821


39.
Cecchetto
G

Amillis
S

Diallinas
G

Scazzocchio
C

Drevet
C


Aspergillus nidulans
. Characterization of a protein belonging to a new phylogenetic cluster
J Biol Chem
2004
279
3132
3141
10.1074/jbc.M308826200

14597637


40.
Vogels
GD

Drift
C


Degradation of purines and pyrimidines by microorganisms
Bacteriol Rev
1976
40
403
468

786256


41.
Scazzocchio
C


The purine degradation pathway, genetics, biochemistry and regulation
Prog Ind Microbiol
1994
29
221
257

7765126


42.
Burton
K


Escherichia coli

Proc Biol Sci
1994
255
153
157
10.1098/rspb.1994.0022

8165228


43.
Koning
HP

Bridges
DJ

Burchmore
RJ


Purine and pyrimidine transport in pathogenic protozoa: from biology to therapy
FEMS Microbiol Rev
2005
29
987
1020
10.1016/j.femsre.2005.03.004

16040150


44.
Koning
HP

Watson
CJ

Sutcliffe
L

Jarvis
SM


Crithidia fasciculata
Trypanosoma brucei brucei

Mol Biochem Parasitol
2000
106
93
107
10.1016/S0166-6851(99)00203-0

10743614


45.
Alleman
MM

Gottlieb
M


Crithidia luciliae

Mol Biochem Parasitol
1996
76
279
287
10.1016/0166-6851(96)02566-2

8920013


46.
Beaman
TC

Hitchins
AD

Ochi
K

Vasantha
N

Endo
T

Freese
E


Bacillus subtilis

J Bacteriol
1983
156
1107
1117

6417108


47.
Nygaard
P

Duckert
P

Saxild
HH


ade
Bacillus subtilis

J Bacteriol
1996
178
846
853

8550522


48.
Cabrita
MA

Baldwin
SA

Young
JD

Cass
CE


Molecular biology and regulation of nucleoside and nucleobase transporter proteins in eukaryotes and prokaryotes
Biochem Cell Biol
2002
80
623
638
10.1139/o02-153

12440702


49.
Griffith
DA

Jarvis
SM


Characterization of a sodium-dependent concentrative nucleobase-transport system in guinea-pig kidney cortex brush-border membrane vesicles
Biochem J
1994
303
901
905

7980460


50.
Griffith
DA

Jarvis
SM


Nucleoside and nucleobase transport systems of mammalian cells
Biochim Biophys Acta
1996
1286
153
181

8982282


51.
Burkle
L

Cedzich
A

Dopke
C

Stransky
H

Okumoto
S

Gillissen
B

Kuhn
C

Frommer
WB


Arabidopsis

Plant J
2003
34
13
26
10.1046/j.1365-313X.2003.01700.x

12662305


52.
Hyde
RJ

Cass
CE

Young
JD

Baldwin
SA


The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms
Mol Membr Biol
2001
18
53
63
10.1080/09687680110033765

11396612


53.
Roy-Burman
S

Visser
DW


Escherichia coli

J Biol Chem
1975
250
9270
9275

1104620



Anke C. Schiedel and Heiko Meyer contributed equally to this work.




